<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Scand J Trauma Resusc Emerg Med</journal-id><journal-id journal-id-type="iso-abbrev">Scand J Trauma Resusc Emerg Med</journal-id><journal-title-group><journal-title>Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine</journal-title></journal-title-group><issn pub-type="epub">1757-7241</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39891247</article-id><article-id pub-id-type="pmc">PMC11786356</article-id><article-id pub-id-type="publisher-id">1331</article-id><article-id pub-id-type="doi">10.1186/s13049-025-01331-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Experimental hypothermia by cold air: a randomized, double-blind, placebo-controlled crossover trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Helland</surname><given-names>Ane M.</given-names></name><address><email>Ane.marthe.helland@norskluftambulanse.no</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Mydske</surname><given-names>Sigurd</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Assmus</surname><given-names>J&#x000f6;rg</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Bratteb&#x000f8;</surname><given-names>Guttorm</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Wiggen</surname><given-names>&#x000d8;ystein</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Kvidaland</surname><given-names>Haakon K.</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Thomassen</surname><given-names>&#x000d8;yvind</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03zga2b32</institution-id><institution-id institution-id-type="GRID">grid.7914.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7443</institution-id><institution>Department of Clinical Medicine, </institution><institution>University of Bergen, </institution></institution-wrap>Storgata 33A, 0103 Bergen, Oslo, Norway </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/045ady436</institution-id><institution-id institution-id-type="GRID">grid.420120.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0481 3017</institution-id><institution>Mountain Medicine Research Group, </institution><institution>The Norwegian Air Ambulance Foundation, </institution></institution-wrap>Bergen, Norway </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03np4e098</institution-id><institution-id institution-id-type="GRID">grid.412008.f</institution-id><institution-id institution-id-type="ISNI">0000 0000 9753 1393</institution-id><institution>Department of Anesthesia and Intensive Care, </institution><institution>Haukeland University Hospital, </institution></institution-wrap>Bergen, Norway </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03np4e098</institution-id><institution-id institution-id-type="GRID">grid.412008.f</institution-id><institution-id institution-id-type="ISNI">0000 0000 9753 1393</institution-id><institution>Norwegian National Advisory Unit On Emergency Medical Communication, </institution><institution>Haukeland University Hospital, </institution></institution-wrap>Bergen, Norway </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/028m52w57</institution-id><institution-id institution-id-type="ISNI">0000 0004 7908 7881</institution-id><institution>Department of Health Research, </institution><institution>SINTEF Digital, </institution></institution-wrap>Trondheim, Norway </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03np4e098</institution-id><institution-id institution-id-type="GRID">grid.412008.f</institution-id><institution-id institution-id-type="ISNI">0000 0000 9753 1393</institution-id><institution>Department of Pediatrics, </institution><institution>Haukeland University Hospital, </institution></institution-wrap>Bergen, Norway </aff></contrib-group><pub-date pub-type="epub"><day>31</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>31</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>33</volume><elocation-id>16</elocation-id><history><date date-type="received"><day>13</day><month>9</month><year>2024</year></date><date date-type="accepted"><day>22</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Accidental hypothermia is associated with high morbidity and mortality. Research on treatment strategies for accidental hypothermia is complicated by the low incidence and heterogeneous patient population. We have developed a new method for clinical trials of experimental hypothermia, to enable further studies of active rewarming. If cold ambient air is effective as a cooling method, this would mimic the most frequent clinical setting of hypothermic patients and provide a feasible cooling method for field studies. We aimed to induce mild hypothermia in healthy volunteers by exposure to cold ambient air, and tested the hypothesis that drug-induced suppression of endogenous thermoregulation would be required.</p></sec><sec><title>Methods</title><p id="Par2">In a randomized, double-blind, crossover design, 15 healthy volunteers wearing wet clothes were put in a windy climate chamber set to 5&#x000a0;&#x000b0;C. Each participant completed the experimental procedure twice, once receiving active drugs (meperidine and buspirone) and once receiving placebo. The experiments were separated by a one-week wash-out period. Primary outcome was core temperature at termination, defined as 3&#x000a0;h of exposure or 35&#x000a0;&#x000b0;C. The between-groups difference was assessed using analysis of covariance (ANCOVA) with left censoring (Tobit model) and individual random intercept. Secondary outcomes were trajectory of core temperature and reduction of shivering.</p></sec><sec><title>Results</title><p id="Par3">At termination, the active drug vs placebo group differed in temperature by 1.4&#x000a0;&#x000b0;C. With adjustment for the removal of participants reaching 35&#x000a0;&#x000b0;C, the estimated mean difference was 1.7&#x000a0;&#x000b0;C (1.4&#x02013;2.0, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001). Shivering was effectively reduced, but not completely inhibited by the drug regimen, and core temperature declined at a rate of&#x02009;&#x02212;&#x02009;0.82&#x000a0;&#x000b0;C per hour.</p></sec><sec><title>Conclusion</title><p id="Par4">The novel protocol utilizing cold air as a cooling method and drug-induced suppression of endogenous thermoregulation, is effective and enables future research projects. We have provided suggestions for minor alterations.</p></sec><sec><title><italic>Trial registration:</italic></title><p id="Par5">EudraCT ID 2023&#x02013;506020-81&#x02013;00.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Accidental hypothermia</kwd><kwd>Thermoregulation</kwd><kwd>Shivering</kwd><kwd>Protocol</kwd><kwd>Prehospital</kwd><kwd>Emergency medicine</kwd><kwd>Mountain medicine</kwd></kwd-group><funding-group><award-group><funding-source><institution>The Norwegian Air Ambulance Foundation</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>University of Bergen (incl Haukeland University Hospital)</institution></funding-source></award-group><open-access><p>Open access funding provided by University of Bergen.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Norwegian Air Ambulance Foundation 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par12">Accidental hypothermia increases morbidity and mortality in many patient groups [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>]. Only limited evidence supports current treatment guidelines, which are mainly based on case reports, retrospective registry studies, and expert opinions [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. By expanding our research methodologies we can provide more certain evidence regarding the management of accidental hypothermia. Conducting clinical trials on hypothermic patients is ethically questionable and would require large sample sizes due to the heterogenicity of this patient group. Studying volunteer research participants is the best alternative. To induce hypothermia in healthy volunteers we hypothesized the need for two interventions: a source of cooling and suppression of the endogenous mechanism of thermoregulation.</p><p id="Par13">In experimental studies of hypothermia, core temperature reduction has been facilitated by cold intravenous (iv.) saline infusions; [<xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR17">17</xref>] cold-water immersion; [<xref ref-type="bibr" rid="CR18">18</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>] or by combinations of iv. infusions, forced air blankets, and/or water mattresses [<xref ref-type="bibr" rid="CR26">26</xref>&#x02013;<xref ref-type="bibr" rid="CR37">37</xref>]. However, our clinical experience, supported by studies, suggests exposure to cold air to be the most frequent etiology of accidental hypothermia [<xref ref-type="bibr" rid="CR38">38</xref>]. Thus, an experimental design in which participants are exposed to cold ambient air would better resemble the clinical setting of most hypothermic patients, and provide data more applicable to patients in the field.</p><p id="Par14">To facilitate core temperature reduction in healthy volunteers, it may be necessary to eliminate shivering. This physiologic response to cold exposure produces considerable endogenous heat, counteracting the desired heat loss. Additionally, shivering is a disruptive factor in studies of hypothermia because the heat produced varies greatly between individuals, and may hide potential effects of exogenous rewarming techniques [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Inhibition of shivering would provide more standardized conditions for research purposes. Meperidine is a synthetic opioid that effectively inhibits shivering at lower equianalgesic dosages compared to other opioids. It is the drug most frequently used in previous studies of hypothermia in awake healthy volunteers [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. Moreover, meperidine combined with the anxiolytic buspirone exhibits a synergistic effect on shivering, reducing the opioid dose required [<xref ref-type="bibr" rid="CR33">33</xref>]. In addition to suppressing shivering, meperidine affects the threshold for vasoconstriction, further enhancing the cooling effect [<xref ref-type="bibr" rid="CR43">43</xref>].</p><p id="Par15">We have developed a protocol tailored to a cold ambient air setting, designing a dosage scheme of meperidine and buspirone to adequately suppress shivering. In the present study, we aimed to evaluate whether our novel protocol for experimental hypothermia using cold ambient air would effectively reduce the core temperature of healthy volunteers. We hypothesized that inhibition of endogenous thermoregulation would be required. The primary outcome was core temperature at termination of the experiment. Secondary outcomes were temperature trajectory and inhibition of shivering.</p></sec><sec id="Sec2"><title>Method</title><sec id="Sec3"><title>Study design</title><p id="Par16">We conducted a randomized, double-blind, placebo-controlled, crossover, phase II clinical drug trial at Haukeland University Hospital, Bergen, Norway, in November 2023. The investigational medicinal products were a combination of meperidine and buspirone, compared to placebo<italic>.</italic> Participants were cooled down twice, once with the use of active drugs and once with placebo, serving as their own control. Each participant was tested at the same time of day, for each of their study days, to avoid circadian effects on body temperature. The two visits were scheduled one week apart to avoid carry-over effect, and to allow adequate wash-out of meperidine.</p></sec></sec><sec id="Sec4"><title>Selection of participants</title><p id="Par17">We enrolled 16 healthy volunteers of 18&#x02013;40&#x000a0;years of age, with body mass index (BMI)&#x02009;&#x0003c;&#x02009;30&#x000a0;kg/m<sup>2</sup>. Female participants provided a urinary sample to exclude pregnancy. Participants were instructed to consume a light meal on each day of experiment; to not use nicotine products at the study site; and to refrain from caffeine, alcohol, grapefruit juice, and strenuous exercise during the 24&#x000a0;h before each experiment. The participants received no payment.</p></sec><sec id="Sec5"><title>Interventions</title><sec id="Sec6"><title>Climate chamber</title><p id="Par18">Active cooling was performed in a refrigerated container, set at 5&#x000a0;&#x000b0;C, measuring 2.3&#x02009;&#x000d7;&#x02009;5.5&#x02009;&#x000d7;&#x02009;2.3&#x000a0;m. The room temperature and humidity were measured every minute by a logger (OMEGA OM-CP-MICRORHTEMP, Stamford, USA), which was placed on the floor behind the participant&#x02019;s head. Participants were instructed to lie in the supine position on isolated sleeping pads (Therm-a-Rest Z-lite, R-value 2.0). Air fans (Ryobi 18&#x000a0;V R18F5-0) were placed at ground level next to the participants&#x02019; feet, and the wind was measured every 20&#x000a0;min by handheld equipment (Testo, Black Forest, Germany) at the thoracic level.</p></sec><sec id="Sec7"><title>Study drugs</title><p id="Par19">A single per os (po.) dose of 30&#x000a0;mg buspirone or placebo was given 60&#x000a0;min prior to active cooling. Meperidine or placebo (saline) was administered in an initial bolus of 1&#x000a0;mg/kg iv., titrated by dividing the dose into five aliquots, each given at 2-min intervals during the last 10&#x000a0;min prior to entering the climate chamber. In the climate chamber, scheduled boluses of 0.5&#x000a0;mg/kg were administered every 30&#x000a0;min. In the event of break-through shivering, an additional &#x0201c;unscheduled&#x0201d; bolus of 0.25&#x000a0;mg/kg was administered. The minimum interval between boluses was set to 5&#x000a0;min. To avoid exceeding a safety limit of 4&#x000a0;mg/kg, no more than two unscheduled additional bolus doses could be administered. After the experiment, we measured normeperidine, a metabolite of meperidine. Drugs and dosages were decided based on a systematic search of the literature (manuscript in preparation).</p><p id="Par20">Identically coated buspirone and placebo tablets were delivered by Krager&#x000f8; Tablettproduksjon to Bergen Hospital Pharmacy, which stored, prepared, labelled, and accounted for both the po. and iv. study drugs. The study drugs were organized in kits, and the content (active drugs or placebo) was determined by a computer-generated randomized list. Each kit contained a sealed envelope containing blind-break information.</p></sec><sec id="Sec8"><title>Preparation</title><p id="Par21">Instrumentation was conducted under thermoneutral indoor conditions. The participants received iv. cannulas for drug administration, transnasal esophageal probes for temperature measurements, a facemask to assess VO<sub>2</sub>, and were connected to equipment for monitoring vitals. Baseline measurements were recorded after 10&#x000a0;min of relaxing in supine position on a portable stretcher. Thereafter, participants were dressed in cotton sweatshirts and sweatpants soaked in cold water, compressed by hand to remove excess water. Participants wore dry mittens, hats, socks, and shoe covers to minimize discomfort and risk of frostbite, and diapers due to anticipated cold-induced diuresis.</p></sec></sec><sec id="Sec9"><title>Experimental procedure</title><p id="Par22">The participants walked into the climate chamber and were cooled until reaching a core temperature of 35&#x000a0;&#x000b0;C, or for a maximum of 3&#x000a0;h (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Timeline. Overview of the timeline on each study day. Includes the preparation phase, the experimental phase, and the rewarming phase. <italic>T</italic>&#x02009;=&#x02009;time on entrance to climate chamber</p></caption><graphic xlink:href="13049_2025_1331_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec10"><title>Measurements</title><sec id="Sec11"><title>Temperature</title><p id="Par23">Temperature was measured every minute using a transnasal esophageal probe inserted to the level of the heart, connected to a Corpuls3 monitor (Corpuls, Kaufering, Germany).</p></sec><sec id="Sec12"><title>Shivering</title><p id="Par24">Oxygen consumption (VO<sub>2</sub>) was measured to indicate shivering, which was defined as a sustained (&#x0003e;&#x02009;1&#x000a0;min) increase of&#x02009;&#x02265;&#x02009;30% from baseline [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Breath-by-breath measurements were obtained using the K5 portable metabolic system (CosMed, Rome, Italy), with OMNIA software v.2.2, and Long-Range Bluetooth 2.1 or USB cables for data transfer, calibrated according to the manufacturer&#x02019;s specifications. The participants wore K5 face masks (CosMed, Rome, Italy) fixed in position by adequate headgear (Hans Rudolph Inc., Kansas City, USA).</p></sec><sec id="Sec13"><title>Safety</title><p id="Par25">To ensure that participants remained within predefined safe ranges, we measured heartrate, blood pressure, oxygen saturation, and ECG using the Corpuls3 monitor. We monitored sedation by Richmond Agitation-Sedation Scale, respiratory rate by K5 described above, skin temperature by iButton&#x000ae; (Maxim integrated products Inc., Whitewater, USA), and normeperidine values. After extrication, participants were actively rewarmed in an infrared sauna until core temperature returned to 36&#x000a0;&#x000b0;C.</p></sec></sec><sec id="Sec14"><title>Outcomes</title><p id="Par26">The primary outcome was defined as core temperature at termination of experiment, comparing active drugs to placebo. Termination was defined by reaching an esophageal temperature of 35&#x000a0;&#x000b0;C, or active cooling exceeding 3&#x000a0;h. Secondary outcomes were trajectory of temperature and inhibition of shivering.</p></sec><sec id="Sec15"><title>Analysis</title><p id="Par27">For sample size calculation, we defined a clinically significant difference between groups (active drugs vs. placebo) as a temperature difference of 0.5&#x000a0;&#x000b0;C at experiment termination. We assumed a standard deviation of 0.5&#x000a0;&#x000b0;C for interindividual variation, and 0.1&#x000a0;&#x000b0;C for intraindividual variation. In all calculated scenarios, 14 participants would yield a power of&#x02009;&#x02265;&#x02009;90%, with a two-sided t-test significance level of 5%.</p><p id="Par28">We used descriptive methods to characterize the sample. The between-groups difference in temperature at termination (primary endpoint) was assessed using the analysis of covariance (ANCOVA) with left censoring at 35&#x000a0;&#x000b0;C (Tobit model) and individual random intercept. This model takes into account the truncation of the temperature distribution at 35&#x000a0;&#x000b0;C (termination criteria) and dependent observations introduced by the cross-over design (two observations per participant). The carry-over effect of the cross-over was assumed to be 0 because of the sufficient wash-out period. We calculated the odds ratio for reaching 35&#x000a0;&#x000b0;C, and used the Haldane-Ascombe correction for the 95% confidence interval (CI) since no shivering participant reached 35&#x000a0;&#x000b0;C [<xref ref-type="bibr" rid="CR44">44</xref>]. The difference between groups in trajectory of temperature and shivering (VO<sub>2</sub>) were assessed using the ANCOVA with individual random intercept at each time-point and the mean (95% CI) of the observed values<italic>.</italic> Shivering was also assessed based on the percentage of VO<sub>2</sub> measurements exceeding baseline value by 30%. The significance level was set to 0.05. We used R 4.4.0 for data handling and computations, and MATLAB (The Mathworks Inc. Natick, MA) for graphics [<xref ref-type="bibr" rid="CR45">45</xref>]. All analyses were performed on all collected data conducted according to protocol. No imputation methods were employed to handle missing data, except for esophageal temperature where single missing values and obviously erratic measurements (temperature&#x02009;&#x0003c;&#x02009;34&#x000a0;&#x000b0;C, or a change of&#x02009;&#x0003e;&#x02009;0.3&#x000a0;&#x000b0;C per minute) were replaced by the average of the 5 previous and 5 following measurements. We aligned the time of measurements between devices using the mean of the measured values per minute.</p></sec><sec id="Sec16"><title>Results</title><p id="Par29">15 participants (for characteristics, see Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>) completed both visits and received the intended treatment in a randomized order (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). The trial was completed in two weeks as scheduled, with no blind break.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Participant- and chamber characteristics</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" colspan="2"><italic>Participants</italic></td></tr><tr><td align="left">Age in years, median [min, max]</td><td align="left">21 [19, 39]</td></tr><tr><td align="left">Female sex, n (%)</td><td align="left">7 (47%)</td></tr><tr><td align="left">BMI in kg/m<sup>2</sup>, mean [min, max]</td><td align="left">24.5 [20.8, 29.3]</td></tr><tr><td align="left" colspan="2"><italic>Climate chamber</italic></td></tr><tr><td align="left">Temperature, &#x000b0;C, median (min, max)</td><td align="left">5.9 (5.5, 6.8)</td></tr><tr><td align="left">Humidity, %, median (min, max)</td><td align="left">88.4 (84.8, 90,5)</td></tr><tr><td align="left">Wind, m/s, median (min, max)</td><td align="left">1.8 (0.9, 2.8)</td></tr></tbody></table></table-wrap><fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Flowchart of study protocol. One participant withdrew the day before the trial due to acute illness</p></caption><graphic xlink:href="13049_2025_1331_Fig2_HTML" id="MO2"/></fig></p><p id="Par30">The temperature at termination differed by 1.4&#x000a0;&#x000b0;C between the active drug and the placebo group. After adjustment for the removal of participants reaching 35&#x000a0;&#x000b0;C, the estimated difference between groups was 1.7&#x000a0;&#x000b0;C (95% CI 1.4&#x000a0;&#x000b0;C to 2.0&#x000a0;&#x000b0;C, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). The odds ratio of 55 (95% CI 3 to 1114) indicates that the group receiving active drugs had 55-times higher odds of reaching 35&#x000a0;&#x000b0;C.<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Core temperature. Esophageal temperature at baseline vs. termination in the active drug (blue) and placebo (orange) group</p></caption><graphic xlink:href="13049_2025_1331_Fig3_HTML" id="MO3"/></fig></p><p id="Par31">Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> presents the trajectory of temperature change for both groups. Upon entering the climate chamber, we could see an increase in core temperature from baseline in the placebo group only. For participants receiving active drugs, core temperature declined at a rate of 0.82&#x000a0;&#x000b0;C/ hour. 10 of the 15 participants receiving active drugs reached 35.0&#x000a0;&#x000b0;C within the allotted timeframe, with a median time to termination of 1.78&#x000a0;h (min. 1.23&#x000a0;h, max. 3&#x000a0;h).<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Temperature trajectory and shivering. Trajectories of esophageal temperature (<bold>a</bold>) and shivering (VO2) (<bold>b</bold>), with 95% CI and P values for the differences between the active drugs (blue) vs. placebo (orange) group. The numbers of observations for all time-points are shown at the bottom. X-axis shows time from entrance into the climate chamber</p></caption><graphic xlink:href="13049_2025_1331_Fig4_HTML" id="MO4"/></fig></p><p id="Par32">Shivering occurred much more frequently in the placebo group compared to the active drugs group (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> illustrates the difference of mean VO<sub>2</sub> in the active drug vs. placebo group. This difference was significant during the first 80&#x000a0;min of the cooling phase, but was no longer significant at the end of the experiment.<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Shivering indicated by increase in oxygen consumption</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" colspan="2"><italic>Shivering (% of VO</italic><sub><italic>2</italic></sub><italic> measurements</italic>&#x02009;&#x02265;&#x02009;<italic>30% from baseline)</italic></td></tr><tr><td align="left">Active drugs, mean (min, max)</td><td char="(" align="char">3.2 (0.3, 18.7)</td></tr><tr><td align="left">Placebo, mean (min, max)</td><td char="(" align="char">59.7 (18.7, 83.7)</td></tr></tbody></table></table-wrap></p><p id="Par33">Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref> displays only the group receiving active drugs. It shows an increase of VO<sub>2</sub> during the minutes preceding each scheduled bolus dose. The participants receiving active drugs are divided in two groups; participants reaching 35&#x000a0;&#x000b0;C within the alotted time frame and participants who did not. The participants reaching 35&#x000a0;&#x000b0;C had a lower oxygen consumption (VO<sub>2</sub>). This difference was present already from the start of cooling, and persisted throughout the experiment.<fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>Shivering in the group receiving active drugs. The participants receiving shiver-inhibiting drugs is here split into two groups: those who reached 35&#x000a0;&#x000b0;C within the allotted timeframe (blue), and those who did not (pink). The number of observations in each group at each time-point is presented below. The stapled vertical lines indicate the timing of maintenance boluses</p></caption><graphic xlink:href="13049_2025_1331_Fig5_HTML" id="MO5"/></fig></p><p id="Par34">The esophageal temperature data from the placebo run of one participant was excluded from analysis, due to a technical error in measurement.</p><p id="Par35">There was no discontinuation of study interventions due to safety issues, and Normeperidine values were within the pre-set safe limit.</p></sec><sec id="Sec17"><title>Discussion</title><p id="Par36">In the present study, we demonstrated the possibility of using exposure to cold ambient air to induce mild hypothermia in volunteer research participants. Our results confirmed our hypothesis that endogenous thermoregulating mechanisms must be inhibited to facilitate adequate reduction of core temperature.</p><p id="Par37">In general, shivering was suppressed by the selected drug regimen, and the inhibition of endogenous heat production enabled core temperature reduction. The lack of a significant difference in shivering between groups during the latter part of the experiment, was partly due to the removal of participants in the active drugs group who reached 35&#x000a0;&#x000b0;C. The participants who reached 35&#x000a0;&#x000b0;C had lower VO<sub>2</sub> values and steeper cooling rates. Upon their removal, the remaining pool of participants may not have been completely shiver inhibited, increasing the mean VO<sub>2</sub> at this time. To accurately measure a loosely defined mechanism is difficult. Shivering is described as involuntary, rapid, repeated contractions of skeletal muscle [<xref ref-type="bibr" rid="CR46">46</xref>]. At rest, increased oxygen consumption (VO<sub>2</sub>) from baseline indicates energy expenditure due to thermogenesis, and thus provides an estimated measure of shivering. The lack of significant difference may also be explained by the sensitive equipment used for breath-by-breath VO<sub>2</sub> measurement; the large variability in VO<sub>2</sub> measurements yielded large spread in the results, with correspondingly large confidence intervals.</p><p id="Par38">Baseline temperatures were similar between the two groups, but we observed that the active and placebo groups differed slightly upon entrance into the chamber. This was likely due to heat generation triggered by the cold stimulus of putting on wet clothes. During the short period between baseline and entrance into chamber, the placebo group was able to thermoregulate, generating heat by shivering and reducing heat loss by vasoconstriction, while the group receiving active drugs could not. Both groups exhibited a small increase of temperature during the first minutes after entrance, which could be attributed to shifts in body position and heat generated by skeletal muscles during the walk from the preparation room to the climate chamber (20&#x000a0;m).</p><p id="Par39">No previous study has described cooling rates in a cold ambient environment when endogenous thermoregulating mechanisms is suppressed. During cold water immersion, reported cooling rates have been&#x02009;&#x02212;&#x02009;3.4&#x000a0;&#x000b0;C/h for immersion in 12&#x000a0;&#x000b0;C water, [<xref ref-type="bibr" rid="CR19">19</xref>] and&#x02009;&#x02212;&#x02009;1.7&#x000a0;&#x000b0;C/h. for immersion in 17&#x000a0;&#x000b0;C water [<xref ref-type="bibr" rid="CR25">25</xref>]. For iv. infusion in 4&#x000a0;&#x000b0;C ringer solution, a cooling rate of&#x02009;&#x02212;&#x02009;2.4&#x000a0;&#x000b0;C has been documented [<xref ref-type="bibr" rid="CR16">16</xref>]. As expected, cold ambient air provides a lesser cold stimulus, yielding a lower cooling rate of&#x02009;&#x02212;&#x02009;0.8&#x000a0;&#x000b0;C/h. When shivering was inhibited, the temperature trajectory followed a predictable pattern with a gradual decline towards hypothermia.</p><p id="Par40">Five participants receiving active drugs did not drop below 35&#x000a0;&#x000b0;C within the allotted timeframe. These participants did not differ in demographics from the group reaching hypothermia. Notably, these five participants had higher VO<sub>2</sub> values present already from the start of experiment, before opioid administration. This suggests that the difference could be due to inherent individual attributes of thermoregulation, including aspects such as individual shivering thresholds or heat-generating abilities, rather than differences in drug distribution and elimination. In general, the shivering data greatly varied between individuals, in accordance with previous studies, [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>] underlining the need for shivering suppression to generate standardized research conditions.</p><p id="Par41">We observed a pattern of increasing VO<sub>2</sub> during the minutes preceding each next scheduled bolus, starting after one hour in the climate chamber (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). This pattern may be due to rapid elimination of meperidine, resulting in break-through shivering. This insufficiency in the dosing scheme could be managed by either increasing the doses or reducing the interval between boluses. The doses were selected based on a review of existing literature [<xref ref-type="bibr" rid="CR18">18</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. Since the initial bolus dose and first scheduled maintenance dose were sufficient for suppressing shivering, we rather suggest decreasing the time interval between scheduled boluses from every 30&#x000a0;min to every 25&#x000a0;min in future protocols. These spikes in VO<sub>2</sub> preceding each maintenance bolus probably results in a heat debt for the next couple of minutes. Reducing these spikes would likely accelerate the heat loss and reduce the time needed to reach mild hypothermia, thus limiting the participants&#x02019; exposure time.</p><p id="Par42">Our protocol was designed to reduce core temperature in volunteers, to facilitate further research on the effect of different active rewarming devices and other treatment options for hypothermic patients. Compared to immersion experiments, our approach to temperature reduction requires less resources, with simplified monitoring and logistics, and thus expands the possibilities for mountain field research. The cooling method replicates typical real-life conditions experienced by patients in a pre-hospital setting, the yielding results will therefore be more applicable to the clinical setting of most patients. Due to the inhibition of shivering, the protocol can also serve as a human model for moderate/severe hypothermia.</p><p id="Par43">One could argue that this non-shivering state is otherwise not clinically relevant, because real patients can generate heat by shivering. However, in quite a few settings, a patient&#x02019;s thermoregulating capacity is no longer intact or has surpassed its limits. This includes patients with moderate (28&#x02013;32&#x000a0;&#x000b0;C) or severe (&#x0003c;&#x02009;28&#x000a0;&#x000b0;C) hypothermia, head injuries, hypoglycemia, [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>] hypothyroidism, [<xref ref-type="bibr" rid="CR51">51</xref>] fatigue, [<xref ref-type="bibr" rid="CR52">52</xref>] intoxication, or iatrogenic causes, such as opioid administration [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR33">33</xref>] by health personnel. Our results suggests that this population may experience steeper cooling rates, not only if submerged or buried in snow, but also in cold ambient temperatures. Health personnel administering opioids or other drugs should be aware of this potential effect on thermoregulation. When encountering a non-shivering patient in a cold environment, one may mistakenly perceive the patient as &#x0201c;not very cold&#x0201d;. We would argue the opposite: if a patient is not benefiting from heat production via shivering, their temperature could be decreasing more rapidly than that of shivering patients.</p></sec><sec id="Sec18"><title>Limitations</title><p id="Par44">Interpretation of the present results is limited to the investigated condition (set temperature, wind, and wet clothing), and to a healthy population of similar age and BMI. The response to temperature manipulation may differ between healthy volunteers with intact resources versus patients. There might be a selection bias towards volunteers more tolerant of cold environments than the average person; however, they might be representative of the population spending time outdoors, and thus more frequently suffer from accidental hypothermia.</p><p id="Par45">Inhibition of shivering alters the body&#x02019;s response to cold. Our selected drugs do not affect thermoregulation solely by inhibiting shivering; thermoregulation is also affected by vasodilation due to histamine release by meperidine, [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>] and by activation of 5-HT1A (serotonin) receptors by buspirone [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. Notably, in contrast to other opioids, meperidine has double the effect on shivering thresholds compared to on vasodilation [<xref ref-type="bibr" rid="CR57">57</xref>]. The mechanism for thermoregulation is ancillary to our primary objective of reducing core temperature. However, when applying the method in further studies and extrapolating results to patients, all effects of the drugs should be considered.</p><p id="Par46">Although this study was blinded, in some cases it became evident to both the participants and investigators whether active or placebo drugs were administered, due to presence or absence of shivering, or the clinical effects of opioids.</p></sec><sec id="Sec19"><title>Conclusion</title><p id="Par47">This novel protocol utilizing cold air as a cooling method, and a tailored drug regimen to suppress endogenous thermoregulation, effectively reduces core temperature in healthy volunteers. We have provided suggestions for minor alterations of the intervals between scheduled maintenance doses.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ANCOVA</term><def><p id="Par6">Analysis of covariance</p></def></def-item><def-item><term>iv.</term><def><p id="Par7">Intravenous</p></def></def-item><def-item><term>BMI</term><def><p id="Par8">Body mass index</p></def></def-item><def-item><term>po.</term><def><p id="Par9">Per os</p></def></def-item><def-item><term>VO<sub>2</sub></term><def><p id="Par10">Oxygen consumption</p></def></def-item><def-item><term>CI</term><def><p id="Par11">Confidence interval</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank our volunteer participants and our research assistants&#x02014;Christian Buen, Vilde Hamre, Sarah Dalen, Sunniva Strand-Tysdal, and Einar M&#x000f8;en&#x02014;for their altruistic contributions. We also express our gratitude to Sivert Helland Veseth and The Vitality Center for Children and Youth at Haukeland University Hospital for outstanding assistance during the trial.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>AMH, SM, JA, GB, OW and OT designed the trial. AMH wrote the protocol and enrolled participants. AMH, SM and OT conducted the trial and data collection. JA performed randomization, statistical analysis and -calculations. HKK performed VO2 measurements and managed the K5 apparatus. AMH drafted, but all authors contributed substantially to and approved the final version of the manuscript. ChatGPT (GPT-4, OpenAI) has been used for the phrasing of single sentences, and San Francisco Edit has provided language editing.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open access funding provided by University of Bergen. The Norwegian Air Ambulance Foundation (NAAF) funded the study. Thanks to Safeguard medical and Algeco for lending us equipment, and to Krager&#x000f8; Tablettproduksjon for the collaboration.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The complete study protocol and the deidentified data subset for this investigation is available upon reasonable request if ethical approval is granted. Contact corresponding author.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par48">The protocol was approved by the Norwegian Ethics Committee for Clinical Trials on Medicinal Products and Medicinal Devices and the Regional Committee for Medicinal and Health Research Ethics Southeast Norway and registered in the EudraCT database (ID 2023&#x02013;506020-81&#x02013;00). Oral and written informed consent was obtained from all participants prior to participation.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par49">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par50">AMH, SM, JA and OT are employed by NAAF. NAAF had no role in the design of the study, do not have access to the data and were not involved in the process of analyzing, interpreting, or publishing the results.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Balvers</surname><given-names>K</given-names></name><name><surname>Van der Horst</surname><given-names>M</given-names></name><name><surname>Graumans</surname><given-names>M</given-names></name><name><surname>Boer</surname><given-names>C</given-names></name><name><surname>Binnekade</surname><given-names>JM</given-names></name><name><surname>Goslings</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Hypothermia as a predictor for mortality in trauma patients at admittance to the Intensive Care Unit</article-title><source>J Emerg Trauma Shock</source><year>2016</year><volume>9</volume><issue>3</issue><fpage>97</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.4103/0974-2700.185276</pub-id><pub-id pub-id-type="pmid">27512330</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Balvers K, Van der Horst M, Graumans M, Boer C, Binnekade JM, Goslings JC, et al. Hypothermia as a predictor for mortality in trauma patients at admittance to the Intensive Care Unit. J Emerg Trauma Shock. 2016;9(3):97&#x02013;102.<pub-id pub-id-type="pmid">27512330</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HE</given-names></name><name><surname>Callaway</surname><given-names>CW</given-names></name><name><surname>Peitzman</surname><given-names>AB</given-names></name><name><surname>Tisherman</surname><given-names>SA</given-names></name></person-group><article-title>Admission hypothermia and outcome after major trauma</article-title><source>Crit Care Med</source><year>2005</year><volume>33</volume><issue>6</issue><fpage>1296</fpage><lpage>1301</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000165965.31895.80</pub-id><pub-id pub-id-type="pmid">15942347</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Wang HE, Callaway CW, Peitzman AB, Tisherman SA. Admission hypothermia and outcome after major trauma. Crit Care Med. 2005;33(6):1296&#x02013;301.<pub-id pub-id-type="pmid">15942347</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Shafi</surname><given-names>S</given-names></name><name><surname>Elliott</surname><given-names>AC</given-names></name><name><surname>Gentilello</surname><given-names>L</given-names></name></person-group><article-title>Is hypothermia simply a marker of shock and injury severity or an independent risk factor for mortality in trauma patients? Analysis of a large national trauma registry</article-title><source>J Trauma</source><year>2005</year><volume>59</volume><issue>5</issue><fpage>1081</fpage><lpage>1085</lpage><pub-id pub-id-type="doi">10.1097/01.ta.0000188647.03665.fd</pub-id><pub-id pub-id-type="pmid">16385283</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Shafi S, Elliott AC, Gentilello L. Is hypothermia simply a marker of shock and injury severity or an independent risk factor for mortality in trauma patients? Analysis of a large national trauma registry. J Trauma. 2005;59(5):1081&#x02013;5.<pub-id pub-id-type="pmid">16385283</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>RS</given-names></name><name><surname>Kilgo</surname><given-names>PD</given-names></name><name><surname>Miller</surname><given-names>PR</given-names></name><name><surname>Hoth</surname><given-names>JJ</given-names></name><name><surname>Meredith</surname><given-names>JW</given-names></name><name><surname>Chang</surname><given-names>MC</given-names></name></person-group><article-title>Injury-associated hypothermia: an analysis of the 2004 National Trauma Data Bank</article-title><source>Shock</source><year>2005</year><volume>24</volume><issue>2</issue><fpage>114</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1097/01.shk.0000169726.25189.b1</pub-id><pub-id pub-id-type="pmid">16044080</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Martin RS, Kilgo PD, Miller PR, Hoth JJ, Meredith JW, Chang MC. Injury-associated hypothermia: an analysis of the 2004 National Trauma Data Bank. Shock. 2005;24(2):114&#x02013;8.<pub-id pub-id-type="pmid">16044080</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>W</given-names></name><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name></person-group><article-title>Low body temperature and mortality in critically ill patients with coronary heart disease: a retrospective analysis from MIMIC-IV database</article-title><source>Eur J Med Res</source><year>2023</year><volume>28</volume><issue>1</issue><fpage>614</fpage><pub-id pub-id-type="doi">10.1186/s40001-023-01584-8</pub-id><pub-id pub-id-type="pmid">38124189</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Luo W, Cao L, Wang C. Low body temperature and mortality in critically ill patients with coronary heart disease: a retrospective analysis from MIMIC-IV database. Eur J Med Res. 2023;28(1):614.<pub-id pub-id-type="pmid">38124189</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">UpToDate WK. Accidental hypothermia in adults 2024 [Available from: <ext-link ext-link-type="uri" xlink:href="https://www.uptodate.com/contents/accidental-hypothermia-in-adults#H17">https://www.uptodate.com/contents/accidental-hypothermia-in-adults#H17</ext-link>.</mixed-citation></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Paal</surname><given-names>P</given-names></name><name><surname>Gordon</surname><given-names>L</given-names></name><name><surname>Strapazzon</surname><given-names>G</given-names></name><name><surname>Brodmann Maeder</surname><given-names>M</given-names></name><name><surname>Putzer</surname><given-names>G</given-names></name><name><surname>Walpoth</surname><given-names>B</given-names></name><etal/></person-group><article-title>Accidental hypothermia-an update : The content of this review is endorsed by the International Commission for Mountain Emergency Medicine (ICAR MEDCOM)</article-title><source>Scand J Trauma Resusc Emerg Med</source><year>2016</year><volume>24</volume><issue>1</issue><fpage>111</fpage><pub-id pub-id-type="doi">10.1186/s13049-016-0303-7</pub-id><pub-id pub-id-type="pmid">27633781</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Paal P, Gordon L, Strapazzon G, Brodmann Maeder M, Putzer G, Walpoth B, et al. Accidental hypothermia-an update&#x0202f;: The content of this review is endorsed by the International Commission for Mountain Emergency Medicine (ICAR MEDCOM). Scand J Trauma Resusc Emerg Med. 2016;24(1):111.<pub-id pub-id-type="pmid">27633781</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Alfonsi</surname><given-names>P</given-names></name><name><surname>Passard</surname><given-names>A</given-names></name><name><surname>Gaude-Joindreau</surname><given-names>V</given-names></name><name><surname>Guignard</surname><given-names>B</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><name><surname>Chauvin</surname><given-names>M</given-names></name></person-group><article-title>Nefopam and alfentanil additively reduce the shivering threshold in humans whereas nefopam and clonidine do not</article-title><source>Anesthesiology</source><year>2009</year><volume>111</volume><issue>1</issue><fpage>102</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e3181a979c1</pub-id><pub-id pub-id-type="pmid">19512866</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Alfonsi P, Passard A, Gaude-Joindreau V, Guignard B, Sessler DI, Chauvin M. Nefopam and alfentanil additively reduce the shivering threshold in humans whereas nefopam and clonidine do not. Anesthesiology. 2009;111(1):102&#x02013;9.<pub-id pub-id-type="pmid">19512866</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Alfonsi</surname><given-names>P</given-names></name><name><surname>Passard</surname><given-names>A</given-names></name><name><surname>Guignard</surname><given-names>B</given-names></name><name><surname>Chauvin</surname><given-names>M</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name></person-group><article-title>Nefopam and meperidine are infra-additive on the shivering threshold in humans</article-title><source>Anesth Analg</source><year>2014</year><volume>119</volume><issue>1</issue><fpage>58</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1213/ANE.0000000000000193</pub-id><pub-id pub-id-type="pmid">24806137</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Alfonsi P, Passard A, Guignard B, Chauvin M, Sessler DI. Nefopam and meperidine are infra-additive on the shivering threshold in humans. Anesth Analg. 2014;119(1):58&#x02013;63.<pub-id pub-id-type="pmid">24806137</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Alfonsi</surname><given-names>P</given-names></name><name><surname>Adam</surname><given-names>F</given-names></name><name><surname>Passard</surname><given-names>A</given-names></name><name><surname>Guignard</surname><given-names>B</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><name><surname>Chauvin</surname><given-names>M</given-names></name></person-group><article-title>Nefopam a nonsedative benzoxazocine analgesic, selectively reduces the shivering threshold in unanesthetized subjects</article-title><source>Anesthesiology</source><year>2004</year><volume>100</volume><issue>1</issue><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1097/00000542-200401000-00010</pub-id><pub-id pub-id-type="pmid">14695722</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Alfonsi P, Adam F, Passard A, Guignard B, Sessler DI, Chauvin M. Nefopam a nonsedative benzoxazocine analgesic, selectively reduces the shivering threshold in unanesthetized subjects. Anesthesiology. 2004;100(1):37&#x02013;43.<pub-id pub-id-type="pmid">14695722</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Delaunay</surname><given-names>L</given-names></name><name><surname>Bonnet</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Beydon</surname><given-names>L</given-names></name><name><surname>Catoire</surname><given-names>P</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name></person-group><article-title>Clonidine comparably decreases the thermoregulatory thresholds for vasoconstriction and shivering in humans</article-title><source>Anesthesiology</source><year>1993</year><volume>79</volume><issue>3</issue><fpage>470</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.1097/00000542-199309000-00009</pub-id><pub-id pub-id-type="pmid">8363071</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Delaunay L, Bonnet F, Liu N, Beydon L, Catoire P, Sessler DI. Clonidine comparably decreases the thermoregulatory thresholds for vasoconstriction and shivering in humans. Anesthesiology. 1993;79(3):470&#x02013;4.<pub-id pub-id-type="pmid">8363071</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Fritz</surname><given-names>HG</given-names></name><name><surname>Hoff</surname><given-names>H</given-names></name><name><surname>Hartmann</surname><given-names>M</given-names></name><name><surname>Karzai</surname><given-names>W</given-names></name><name><surname>Schwarzkopf</surname><given-names>KRG</given-names></name></person-group><article-title>The effects of urapidil on thermoregulatory thresholds in volunteers</article-title><source>Anesth Analg</source><year>2002</year><volume>94</volume><issue>3</issue><fpage>626</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1097/00000539-200203000-00027</pub-id><pub-id pub-id-type="pmid">11867387</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Fritz HG, Hoff H, Hartmann M, Karzai W, Schwarzkopf KRG. The effects of urapidil on thermoregulatory thresholds in volunteers. Anesth Analg. 2002;94(3):626&#x02013;30.<pub-id pub-id-type="pmid">11867387</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Hostler</surname><given-names>D</given-names></name><name><surname>Northington</surname><given-names>WE</given-names></name><name><surname>Callaway</surname><given-names>CW</given-names></name></person-group><article-title>High-dose diazepam facilitates core cooling during cold saline infusion in healthy volunteers</article-title><source>Appl Physiol Nutr Metab</source><year>2009</year><volume>34</volume><issue>4</issue><fpage>582</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1139/H09-011</pub-id><pub-id pub-id-type="pmid">19767791</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Hostler D, Northington WE, Callaway CW. High-dose diazepam facilitates core cooling during cold saline infusion in healthy volunteers. Appl Physiol Nutr Metab. 2009;34(4):582&#x02013;6.<pub-id pub-id-type="pmid">19767791</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>T</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><name><surname>Tayefeh</surname><given-names>F</given-names></name><name><surname>Negishi</surname><given-names>C</given-names></name><name><surname>Turakhia</surname><given-names>M</given-names></name><name><surname>Marder</surname><given-names>D</given-names></name><etal/></person-group><article-title>Meperidine and alfentanil do not reduce the gain or maximum intensity of shivering</article-title><source>Anesthesiology</source><year>1998</year><volume>88</volume><issue>4</issue><fpage>858</fpage><lpage>865</lpage><pub-id pub-id-type="doi">10.1097/00000542-199804000-00003</pub-id><pub-id pub-id-type="pmid">9579492</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Ikeda T, Sessler DI, Tayefeh F, Negishi C, Turakhia M, Marder D, et al. Meperidine and alfentanil do not reduce the gain or maximum intensity of shivering. Anesthesiology. 1998;88(4):858&#x02013;65.<pub-id pub-id-type="pmid">9579492</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Ittner</surname><given-names>KP</given-names></name><name><surname>Bachfischer</surname><given-names>M</given-names></name><name><surname>Faerber</surname><given-names>L</given-names></name><name><surname>Taeger</surname><given-names>K</given-names></name></person-group><article-title>Effect of tropisetron versus placebo on cold-induced oxygen consumption and shivering in male volunteers</article-title><source>J Therm Biol</source><year>2004</year><volume>29</volume><fpage>845</fpage><lpage>849</lpage><pub-id pub-id-type="doi">10.1016/j.jtherbio.2004.08.066</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Ittner KP, Bachfischer M, Faerber L, Taeger K. Effect of tropisetron versus placebo on cold-induced oxygen consumption and shivering in male volunteers. J Therm Biol. 2004;29:845&#x02013;9.</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Kimberger</surname><given-names>O</given-names></name><name><surname>Ali</surname><given-names>SZ</given-names></name><name><surname>Markstaller</surname><given-names>M</given-names></name><name><surname>Zmoos</surname><given-names>S</given-names></name><name><surname>Lauber</surname><given-names>R</given-names></name><name><surname>Hunkeler</surname><given-names>C</given-names></name><etal/></person-group><article-title>Meperidine and skin surface warming additively reduce the shivering threshold: a volunteer study</article-title><source>Crit Care</source><year>2007</year><volume>11</volume><issue>1</issue><fpage>R29</fpage><pub-id pub-id-type="doi">10.1186/cc5709</pub-id><pub-id pub-id-type="pmid">17316456</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Kimberger O, Ali SZ, Markstaller M, Zmoos S, Lauber R, Hunkeler C, et al. Meperidine and skin surface warming additively reduce the shivering threshold: a volunteer study. Crit Care. 2007;11(1):R29.<pub-id pub-id-type="pmid">17316456</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Kurz</surname><given-names>M</given-names></name><name><surname>Belani</surname><given-names>KG</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><name><surname>Kurz</surname><given-names>A</given-names></name><name><surname>Larson</surname><given-names>MD</given-names></name><name><surname>Schroeder</surname><given-names>M</given-names></name><etal/></person-group><article-title>Naloxone, meperidine, and shivering</article-title><source>Anesthesiology</source><year>1993</year><volume>79</volume><issue>6</issue><fpage>1193</fpage><lpage>1201</lpage><pub-id pub-id-type="doi">10.1097/00000542-199312000-00009</pub-id><pub-id pub-id-type="pmid">8267194</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Kurz M, Belani KG, Sessler DI, Kurz A, Larson MD, Schroeder M, et al. Naloxone, meperidine, and shivering. Anesthesiology. 1993;79(6):1193&#x02013;201.<pub-id pub-id-type="pmid">8267194</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Giesbrecht</surname><given-names>GG</given-names></name><name><surname>Goheen</surname><given-names>MS</given-names></name><name><surname>Johnston</surname><given-names>CE</given-names></name><name><surname>Kenny</surname><given-names>GP</given-names></name><name><surname>Bristow</surname><given-names>GK</given-names></name><name><surname>Hayward</surname><given-names>JS</given-names></name></person-group><article-title>Inhibition of shivering increases core temperature afterdrop and attenuates rewarming in hypothermic humans</article-title><source>J Appl Physiol</source><year>1997</year><volume>83</volume><issue>5</issue><fpage>1630</fpage><lpage>1634</lpage><pub-id pub-id-type="doi">10.1152/jappl.1997.83.5.1630</pub-id><pub-id pub-id-type="pmid">9375331</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Giesbrecht GG, Goheen MS, Johnston CE, Kenny GP, Bristow GK, Hayward JS. Inhibition of shivering increases core temperature afterdrop and attenuates rewarming in hypothermic humans. J Appl Physiol. 1997;83(5):1630&#x02013;4.<pub-id pub-id-type="pmid">9375331</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Giesbrecht</surname><given-names>GG</given-names></name><name><surname>Lockhart</surname><given-names>TL</given-names></name><name><surname>Bristow</surname><given-names>GK</given-names></name><name><surname>Steinman</surname><given-names>AM</given-names></name></person-group><article-title>Thermal effects of dorsal head immersion in cold water on nonshivering humans</article-title><source>J Appl Physiol</source><year>2005</year><volume>99</volume><issue>5</issue><fpage>1958</fpage><lpage>1964</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00052.2005</pub-id><pub-id pub-id-type="pmid">16227460</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Giesbrecht GG, Lockhart TL, Bristow GK, Steinman AM. Thermal effects of dorsal head immersion in cold water on nonshivering humans. J Appl Physiol. 2005;99(5):1958&#x02013;64.<pub-id pub-id-type="pmid">16227460</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Goheen</surname><given-names>MS</given-names></name><name><surname>Ducharme</surname><given-names>MB</given-names></name><name><surname>Kenny</surname><given-names>GP</given-names></name><name><surname>Johnston</surname><given-names>CE</given-names></name><name><surname>Frim</surname><given-names>J</given-names></name><name><surname>Bristow</surname><given-names>GK</given-names></name><etal/></person-group><article-title>Efficacy of forced-air and inhalation rewarming by using a human model for severe hypothermia</article-title><source>J Appl Physiol</source><year>1997</year><volume>83</volume><issue>5</issue><fpage>1635</fpage><lpage>1640</lpage><pub-id pub-id-type="doi">10.1152/jappl.1997.83.5.1635</pub-id><pub-id pub-id-type="pmid">9375332</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Goheen MS, Ducharme MB, Kenny GP, Johnston CE, Frim J, Bristow GK, et al. Efficacy of forced-air and inhalation rewarming by using a human model for severe hypothermia. J Appl Physiol. 1997;83(5):1635&#x02013;40.<pub-id pub-id-type="pmid">9375332</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Hultzer</surname><given-names>MV</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Marrao</surname><given-names>C</given-names></name><name><surname>Bristow</surname><given-names>G</given-names></name><name><surname>Chochinov</surname><given-names>A</given-names></name><name><surname>Giesbrecht</surname><given-names>GG</given-names></name></person-group><article-title>Pre-hospital torso-warming modalities for severe hypothermia: a comparative study using a human model</article-title><source>Cana J Emerg Med</source><year>2005</year><volume>7</volume><issue>6</issue><fpage>378</fpage><lpage>386</lpage></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Hultzer MV, Xu X, Marrao C, Bristow G, Chochinov A, Giesbrecht GG. Pre-hospital torso-warming modalities for severe hypothermia: a comparative study using a human model. Cana J Emerg Med. 2005;7(6):378&#x02013;86.</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Hurrie</surname><given-names>DMG</given-names></name><name><surname>Hildebrand</surname><given-names>E</given-names></name><name><surname>Arnould</surname><given-names>SM</given-names></name><name><surname>Plett</surname><given-names>J</given-names></name><name><surname>Bellan</surname><given-names>D</given-names></name><name><surname>Buchel</surname><given-names>A</given-names></name><etal/></person-group><article-title>Comparison of electric resistive heating pads and forced-air warming for pre-hospital warming of non-shivering hypothermic subjects</article-title><source>Mil Med</source><year>2020</year><volume>185</volume><issue>1&#x02013;2</issue><fpage>e154</fpage><lpage>e161</lpage><pub-id pub-id-type="pmid">31295348</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Hurrie DMG, Hildebrand E, Arnould SM, Plett J, Bellan D, Buchel A, et al. Comparison of electric resistive heating pads and forced-air warming for pre-hospital warming of non-shivering hypothermic subjects. Mil Med. 2020;185(1&#x02013;2):e154&#x02013;61.<pub-id pub-id-type="pmid">31295348</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Kulkarni</surname><given-names>K</given-names></name><name><surname>Hildahl</surname><given-names>E</given-names></name><name><surname>Dutta</surname><given-names>R</given-names></name><name><surname>Webber</surname><given-names>SC</given-names></name><name><surname>Passmore</surname><given-names>S</given-names></name><name><surname>McDonald</surname><given-names>GK</given-names></name><etal/></person-group><article-title>Efficacy of head and torso rewarming using a human model for severe hypothermia</article-title><source>Wilderness Environ Med</source><year>2019</year><volume>30</volume><issue>1</issue><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.wem.2018.11.005</pub-id><pub-id pub-id-type="pmid">30737153</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Kulkarni K, Hildahl E, Dutta R, Webber SC, Passmore S, McDonald GK, et al. Efficacy of head and torso rewarming using a human model for severe hypothermia. Wilderness Environ Med. 2019;30(1):35&#x02013;43.<pub-id pub-id-type="pmid">30737153</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Lundgren</surname><given-names>JP</given-names></name><name><surname>Henriksson</surname><given-names>O</given-names></name><name><surname>Pretorius</surname><given-names>T</given-names></name><name><surname>Cahill</surname><given-names>F</given-names></name><name><surname>Bristow</surname><given-names>G</given-names></name><name><surname>Chochinov</surname><given-names>A</given-names></name><etal/></person-group><article-title>Field torso-warming modalities: a comparative study using a human model</article-title><source>Prehosp Emerg Care</source><year>2009</year><volume>13</volume><issue>3</issue><fpage>371</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1080/10903120902935348</pub-id><pub-id pub-id-type="pmid">19499476</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Lundgren JP, Henriksson O, Pretorius T, Cahill F, Bristow G, Chochinov A, et al. Field torso-warming modalities: a comparative study using a human model. Prehosp Emerg Care. 2009;13(3):371&#x02013;8.<pub-id pub-id-type="pmid">19499476</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Pretorius</surname><given-names>T</given-names></name><name><surname>Bristow</surname><given-names>GK</given-names></name><name><surname>Steinman</surname><given-names>AM</given-names></name><name><surname>Giesbrecht</surname><given-names>GG</given-names></name></person-group><article-title>Thermal effects of whole head submersion in cold water on nonshivering humans</article-title><source>J Appl Physiol</source><year>2006</year><volume>101</volume><issue>2</issue><fpage>669</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01241.2005</pub-id><pub-id pub-id-type="pmid">16614357</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Pretorius T, Bristow GK, Steinman AM, Giesbrecht GG. Thermal effects of whole head submersion in cold water on nonshivering humans. J Appl Physiol. 2006;101(2):669&#x02013;75.<pub-id pub-id-type="pmid">16614357</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Doufas</surname><given-names>AG</given-names></name><name><surname>Lin</surname><given-names>CM</given-names></name><name><surname>Suleman</surname><given-names>MI</given-names></name><name><surname>Liem</surname><given-names>EB</given-names></name><name><surname>Lenhardt</surname><given-names>R</given-names></name><name><surname>Morioka</surname><given-names>N</given-names></name><etal/></person-group><article-title>Dexmedetomidine and meperidine additively reduce the shivering threshold in humans</article-title><source>Stroke</source><year>2003</year><volume>34</volume><issue>5</issue><fpage>1218</fpage><lpage>1223</lpage><pub-id pub-id-type="doi">10.1161/01.STR.0000068787.76670.A4</pub-id><pub-id pub-id-type="pmid">12690216</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Doufas AG, Lin CM, Suleman MI, Liem EB, Lenhardt R, Morioka N, et al. Dexmedetomidine and meperidine additively reduce the shivering threshold in humans. Stroke. 2003;34(5):1218&#x02013;23.<pub-id pub-id-type="pmid">12690216</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Kimberger</surname><given-names>O</given-names></name><name><surname>Held</surname><given-names>C</given-names></name><name><surname>Stadelmann</surname><given-names>K</given-names></name><name><surname>Mayer</surname><given-names>N</given-names></name><name><surname>Hunkeler</surname><given-names>C</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><etal/></person-group><article-title>Resistive polymer versus forced-air warming: Comparable heat transfer and core rewarming rates in volunteers</article-title><source>Anesth Analg</source><year>2008</year><volume>107</volume><issue>5</issue><fpage>1621</fpage><lpage>1626</lpage><pub-id pub-id-type="doi">10.1213/ane.0b013e3181845502</pub-id><pub-id pub-id-type="pmid">18931221</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Kimberger O, Held C, Stadelmann K, Mayer N, Hunkeler C, Sessler DI, et al. Resistive polymer versus forced-air warming: Comparable heat transfer and core rewarming rates in volunteers. Anesth Analg. 2008;107(5):1621&#x02013;6.<pub-id pub-id-type="pmid">18931221</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Komatsu</surname><given-names>R</given-names></name><name><surname>Orhan-Sungur</surname><given-names>M</given-names></name><name><surname>In</surname><given-names>J</given-names></name><name><surname>Podranski</surname><given-names>T</given-names></name><name><surname>Bouillon</surname><given-names>T</given-names></name><name><surname>Lauber</surname><given-names>R</given-names></name><etal/></person-group><article-title>Ondansetron does not reduce the shivering threshold in healthy volunteers</article-title><source>Br J Anaesth</source><year>2006</year><volume>96</volume><issue>6</issue><fpage>732</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1093/bja/ael101</pub-id><pub-id pub-id-type="pmid">16675509</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Komatsu R, Orhan-Sungur M, In J, Podranski T, Bouillon T, Lauber R, et al. Ondansetron does not reduce the shivering threshold in healthy volunteers. Br J Anaesth. 2006;96(6):732&#x02013;7.<pub-id pub-id-type="pmid">16675509</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Kurz</surname><given-names>A</given-names></name><name><surname>Go</surname><given-names>JC</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><name><surname>Kaer</surname><given-names>K</given-names></name><name><surname>Larson</surname><given-names>MD</given-names></name><name><surname>Bjorksten</surname><given-names>AR</given-names></name></person-group><article-title>Alfentanil slightly increases the sweating threshold and markedly reduces the vasoconstriction and shivering thresholds</article-title><source>Anesthesiology</source><year>1995</year><volume>83</volume><issue>2</issue><fpage>293</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1097/00000542-199508000-00009</pub-id><pub-id pub-id-type="pmid">7631951</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Kurz A, Go JC, Sessler DI, Kaer K, Larson MD, Bjorksten AR. Alfentanil slightly increases the sweating threshold and markedly reduces the vasoconstriction and shivering thresholds. Anesthesiology. 1995;83(2):293&#x02013;9.<pub-id pub-id-type="pmid">7631951</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Kurz</surname><given-names>A</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><name><surname>Annadata</surname><given-names>R</given-names></name><name><surname>Dechert</surname><given-names>M</given-names></name><name><surname>Christensen</surname><given-names>R</given-names></name><name><surname>Bjorksten</surname><given-names>AR</given-names></name></person-group><article-title>Midazolam minimally impairs thermoregulatory control</article-title><source>Anesth Analg</source><year>1995</year><volume>81</volume><issue>2</issue><fpage>393</fpage><lpage>398</lpage><pub-id pub-id-type="pmid">7618734</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Kurz A, Sessler DI, Annadata R, Dechert M, Christensen R, Bjorksten AR. Midazolam minimally impairs thermoregulatory control. Anesth Analg. 1995;81(2):393&#x02013;8.<pub-id pub-id-type="pmid">7618734</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Lenhardt</surname><given-names>R</given-names></name><name><surname>Orhan-Sungur</surname><given-names>M</given-names></name><name><surname>Komatsu</surname><given-names>R</given-names></name><name><surname>Govinda</surname><given-names>R</given-names></name><name><surname>Kasuya</surname><given-names>Y</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><etal/></person-group><article-title>Suppression of shivering during hypothermia using a novel drug combination in healthy volunteers</article-title><source>Anesthesiology</source><year>2009</year><volume>111</volume><issue>1</issue><fpage>110</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e3181a979a3</pub-id><pub-id pub-id-type="pmid">19512867</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Lenhardt R, Orhan-Sungur M, Komatsu R, Govinda R, Kasuya Y, Sessler DI, et al. Suppression of shivering during hypothermia using a novel drug combination in healthy volunteers. Anesthesiology. 2009;111(1):110&#x02013;5.<pub-id pub-id-type="pmid">19512867</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>CM</given-names></name><name><surname>Neeru</surname><given-names>S</given-names></name><name><surname>Doufas</surname><given-names>AG</given-names></name><name><surname>Liem</surname><given-names>E</given-names></name><name><surname>Muneer Shah</surname><given-names>Y</given-names></name><name><surname>Wadhwa</surname><given-names>A</given-names></name><etal/></person-group><article-title>Dantrolene reduces the threshold and gain for shivering</article-title><source>Anesth Anal</source><year>2004</year><volume>98</volume><issue>5</issue><fpage>1318</fpage><lpage>1324</lpage><pub-id pub-id-type="doi">10.1213/01.ANE.0000108968.21212.D7</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Lin CM, Neeru S, Doufas AG, Liem E, Muneer Shah Y, Wadhwa A, et al. Dantrolene reduces the threshold and gain for shivering. Anesth Anal. 2004;98(5):1318&#x02013;24.</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Mokhtarani</surname><given-names>M</given-names></name><name><surname>Mahgoub</surname><given-names>AN</given-names></name><name><surname>Morioka</surname><given-names>N</given-names></name><name><surname>Doufas</surname><given-names>AG</given-names></name><name><surname>Dae</surname><given-names>M</given-names></name><name><surname>Shaughnessy</surname><given-names>TE</given-names></name><etal/></person-group><article-title>Buspirone and meperidine synergistically reduce the shivering threshold</article-title><source>Anesth Analg</source><year>2001</year><volume>93</volume><issue>5</issue><fpage>1233</fpage><lpage>1239</lpage><pub-id pub-id-type="doi">10.1097/00000539-200111000-00038</pub-id><pub-id pub-id-type="pmid">11682404</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Mokhtarani M, Mahgoub AN, Morioka N, Doufas AG, Dae M, Shaughnessy TE, et al. Buspirone and meperidine synergistically reduce the shivering threshold. Anesth Analg. 2001;93(5):1233&#x02013;9.<pub-id pub-id-type="pmid">11682404</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Rittenberger</surname><given-names>JC</given-names></name><name><surname>Weissman</surname><given-names>A</given-names></name><name><surname>Flickinger</surname><given-names>KL</given-names></name><name><surname>Guyette</surname><given-names>FX</given-names></name><name><surname>Hopkins</surname><given-names>D</given-names></name><name><surname>Repine</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Glycopyrrolate does not ameliorate hypothermia associated bradycardia in healthy individuals: A randomized crossover trial</article-title><source>Resuscitation</source><year>2021</year><volume>164</volume><fpage>79</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.resuscitation.2021.05.020</pub-id><pub-id pub-id-type="pmid">34087418</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Rittenberger JC, Weissman A, Flickinger KL, Guyette FX, Hopkins D, Repine MJ, et al. Glycopyrrolate does not ameliorate hypothermia associated bradycardia in healthy individuals: A randomized crossover trial. Resuscitation. 2021;164:79&#x02013;83.<pub-id pub-id-type="pmid">34087418</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Talke</surname><given-names>P</given-names></name><name><surname>Tayefeh</surname><given-names>F</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><name><surname>Jeffrey</surname><given-names>R</given-names></name><name><surname>Noursalehi</surname><given-names>M</given-names></name><name><surname>Richardson</surname><given-names>C</given-names></name></person-group><article-title>Dexmedetomidine does not alter the sweating threshold, but comparably and linearly decreases the vasoconstriction and shivering thresholds</article-title><source>Anesthesiology</source><year>1997</year><volume>87</volume><issue>4</issue><fpage>835</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1097/00000542-199710000-00017</pub-id><pub-id pub-id-type="pmid">9357885</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Talke P, Tayefeh F, Sessler DI, Jeffrey R, Noursalehi M, Richardson C. Dexmedetomidine does not alter the sweating threshold, but comparably and linearly decreases the vasoconstriction and shivering thresholds. Anesthesiology. 1997;87(4):835&#x02013;41.<pub-id pub-id-type="pmid">9357885</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>Y</given-names></name><name><surname>Ali</surname><given-names>SZ</given-names></name><name><surname>Kimberger</surname><given-names>O</given-names></name><name><surname>Zmoos</surname><given-names>S</given-names></name><name><surname>Lauber</surname><given-names>R</given-names></name><name><surname>Markstaller</surname><given-names>M</given-names></name><etal/></person-group><article-title>The effects of nefopam on the gain and maximum intensity of shivering in healthy volunteers</article-title><source>Anesth Analg</source><year>2010</year><volume>111</volume><issue>2</issue><fpage>409</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1213/ANE.0b013e3181e332bb</pub-id><pub-id pub-id-type="pmid">20529984</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Taniguchi Y, Ali SZ, Kimberger O, Zmoos S, Lauber R, Markstaller M, et al. The effects of nefopam on the gain and maximum intensity of shivering in healthy volunteers. Anesth Analg. 2010;111(2):409&#x02013;14.<pub-id pub-id-type="pmid">20529984</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Wadhwa</surname><given-names>A</given-names></name><name><surname>Sengupta</surname><given-names>P</given-names></name><name><surname>Durrani</surname><given-names>J</given-names></name><name><surname>Akca</surname><given-names>O</given-names></name><name><surname>Lenhardt</surname><given-names>R</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><etal/></person-group><article-title>Magnesium sulphate only slightly reduces the shivering threshold in humans</article-title><source>Br J Anaesth</source><year>2005</year><volume>94</volume><issue>6</issue><fpage>756</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.1093/bja/aei105</pub-id><pub-id pub-id-type="pmid">15749735</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Wadhwa A, Sengupta P, Durrani J, Akca O, Lenhardt R, Sessler DI, et al. Magnesium sulphate only slightly reduces the shivering threshold in humans. Br J Anaesth. 2005;94(6):756&#x02013;62.<pub-id pub-id-type="pmid">15749735</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Kosi&#x00144;ski</surname><given-names>S</given-names></name><name><surname>Darocha</surname><given-names>T</given-names></name><name><surname>Ga&#x00142;&#x00105;zkowski</surname><given-names>R</given-names></name><name><surname>Drwi&#x00142;a</surname><given-names>R</given-names></name></person-group><article-title>Accidental hypothermia in Poland &#x02013; estimation of prevalence, diagnostic methods and treatment</article-title><source>Scand J Trauma Resusc Emerg Med</source><year>2015</year><volume>23</volume><fpage>13</fpage><pub-id pub-id-type="doi">10.1186/s13049-014-0086-7</pub-id><pub-id pub-id-type="pmid">25655922</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Kosi&#x00144;ski S, Darocha T, Ga&#x00142;&#x00105;zkowski R, Drwi&#x00142;a R. Accidental hypothermia in Poland &#x02013; estimation of prevalence, diagnostic methods and treatment. Scand J Trauma Resusc Emerg Med. 2015;23:13.<pub-id pub-id-type="pmid">25655922</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Brychta</surname><given-names>RJ</given-names></name><name><surname>Chen</surname><given-names>KY</given-names></name></person-group><article-title>Cold-induced thermogenesis in humans</article-title><source>Eur J Clin Nutr</source><year>2017</year><volume>71</volume><issue>3</issue><fpage>345</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1038/ejcn.2016.223</pub-id><pub-id pub-id-type="pmid">27876809</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Brychta RJ, Chen KY. Cold-induced thermogenesis in humans. Eur J Clin Nutr. 2017;71(3):345&#x02013;52.<pub-id pub-id-type="pmid">27876809</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Haman</surname><given-names>F</given-names></name><name><surname>Blondin</surname><given-names>DP</given-names></name></person-group><article-title>Shivering thermogenesis in humans: origin, contribution and metabolic requirement</article-title><source>Temperature</source><year>2017</year><volume>4</volume><issue>3</issue><fpage>217</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1080/23328940.2017.1328999</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Haman F, Blondin DP. Shivering thermogenesis in humans: origin, contribution and metabolic requirement. Temperature. 2017;4(3):217&#x02013;26.</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Zweifler</surname><given-names>RM</given-names></name><name><surname>Voorhees</surname><given-names>ME</given-names></name><name><surname>Mahmood</surname><given-names>MA</given-names></name><name><surname>Alday</surname><given-names>DD</given-names></name></person-group><article-title>Induction and maintenance of mild hypothermia by surface cooling in non-intubated subjects</article-title><source>J Stroke Cerebrovasc Dis</source><year>2003</year><volume>12</volume><issue>5</issue><fpage>237</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2003.09.006</pub-id><pub-id pub-id-type="pmid">17903934</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Zweifler RM, Voorhees ME, Mahmood MA, Alday DD. Induction and maintenance of mild hypothermia by surface cooling in non-intubated subjects. J Stroke Cerebrovasc Dis. 2003;12(5):237&#x02013;43.<pub-id pub-id-type="pmid">17903934</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Zweifler</surname><given-names>RM</given-names></name><name><surname>Voorhees</surname><given-names>ME</given-names></name><name><surname>Mahmood</surname><given-names>MA</given-names></name><name><surname>Parnell</surname><given-names>M</given-names></name></person-group><article-title>Magnesium sulfate increases the rate of hypothermia via surface cooling and improves comfort</article-title><source>Stroke</source><year>2004</year><volume>35</volume><issue>10</issue><fpage>2331</fpage><lpage>2334</lpage><pub-id pub-id-type="doi">10.1161/01.STR.0000141161.63181.f1</pub-id><pub-id pub-id-type="pmid">15322301</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Zweifler RM, Voorhees ME, Mahmood MA, Parnell M. Magnesium sulfate increases the rate of hypothermia via surface cooling and improves comfort. Stroke. 2004;35(10):2331&#x02013;4.<pub-id pub-id-type="pmid">15322301</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Kurz</surname><given-names>A</given-names></name><name><surname>Ikeda</surname><given-names>T</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><name><surname>Larson</surname><given-names>MD</given-names></name><name><surname>Bjorksten</surname><given-names>AR</given-names></name><name><surname>Dechert</surname><given-names>M</given-names></name><etal/></person-group><article-title>Meperidine decreases the shivering threshold twice as much as the vasoconstriction threshold</article-title><source>Anesthesiology</source><year>1997</year><volume>86</volume><issue>5</issue><fpage>1046</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.1097/00000542-199705000-00007</pub-id><pub-id pub-id-type="pmid">9158353</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Kurz A, Ikeda T, Sessler DI, Larson MD, Bjorksten AR, Dechert M, et al. Meperidine decreases the shivering threshold twice as much as the vasoconstriction threshold. Anesthesiology. 1997;86(5):1046&#x02013;54.<pub-id pub-id-type="pmid">9158353</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Ruxton</surname><given-names>GD</given-names></name><name><surname>Neuhauser</surname><given-names>M</given-names></name></person-group><article-title>Review of alternative approaches to calculation of a confidence interval for the odds ratio of a 2X2 contingency table</article-title><source>Methods Ecol Evol</source><year>2013</year><volume>4</volume><fpage>9</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1111/j.2041-210x.2012.00250.x</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Ruxton GD, Neuhauser M. Review of alternative approaches to calculation of a confidence interval for the odds ratio of a 2X2 contingency table. Methods Ecol Evol. 2013;4:9&#x02013;13.</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="book"><person-group person-group-type="author"><name><surname>R</surname><given-names>RCT</given-names></name></person-group><source>A Language and Environment for Statistical Computing R Foundation for Statistical Computing</source><year>2024</year><publisher-loc>Vienna</publisher-loc><publisher-name>Austria</publisher-name></element-citation><mixed-citation id="mc-CR45" publication-type="book">R RCT. A Language and Environment for Statistical Computing R Foundation for Statistical Computing. Vienna: Austria; 2024.</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Morrison</surname><given-names>SF</given-names></name></person-group><article-title>Central efferent pathways for cold-defensive and febrile shivering</article-title><source>J Physiol</source><year>2011</year><volume>589</volume><issue>Pt 14</issue><fpage>3641</fpage><lpage>3658</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2011.210047</pub-id><pub-id pub-id-type="pmid">21610139</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Nakamura K, Morrison SF. Central efferent pathways for cold-defensive and febrile shivering. J Physiol. 2011;589(Pt 14):3641&#x02013;58.<pub-id pub-id-type="pmid">21610139</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Eyolfson</surname><given-names>DA</given-names></name><name><surname>Tikuisis</surname><given-names>P</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Weseen</surname><given-names>G</given-names></name><name><surname>Giesbrecht</surname><given-names>GG</given-names></name></person-group><article-title>Measurement and prediction of peak shivering intensity in humans</article-title><source>Eur J Appl Physiol</source><year>2001</year><volume>84</volume><issue>1&#x02013;2</issue><fpage>100</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1007/s004210000329</pub-id><pub-id pub-id-type="pmid">11394237</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Eyolfson DA, Tikuisis P, Xu X, Weseen G, Giesbrecht GG. Measurement and prediction of peak shivering intensity in humans. Eur J Appl Physiol. 2001;84(1&#x02013;2):100&#x02013;6.<pub-id pub-id-type="pmid">11394237</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Haman</surname><given-names>F</given-names></name><name><surname>Blondin</surname><given-names>DP</given-names></name><name><surname>Imbeault</surname><given-names>MA</given-names></name><name><surname>Maneshi</surname><given-names>A</given-names></name></person-group><article-title>Metabolic requirements of shivering humans</article-title><source>Front Biosci (Schol Ed)</source><year>2010</year><volume>2</volume><issue>3</issue><fpage>1155</fpage><lpage>1168</lpage><pub-id pub-id-type="doi">10.2741/s124</pub-id><pub-id pub-id-type="pmid">20515847</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Haman F, Blondin DP, Imbeault MA, Maneshi A. Metabolic requirements of shivering humans. Front Biosci (Schol Ed). 2010;2(3):1155&#x02013;68.<pub-id pub-id-type="pmid">20515847</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Gale</surname><given-names>EA</given-names></name><name><surname>Bennett</surname><given-names>T</given-names></name><name><surname>Green</surname><given-names>JH</given-names></name><name><surname>MacDonald</surname><given-names>IA</given-names></name></person-group><article-title>Hypoglycaemia, hypothermia and shivering in man</article-title><source>Clin Sci (Lond)</source><year>1981</year><volume>61</volume><issue>4</issue><fpage>463</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1042/cs0610463</pub-id><pub-id pub-id-type="pmid">7026128</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Gale EA, Bennett T, Green JH, MacDonald IA. Hypoglycaemia, hypothermia and shivering in man. Clin Sci (Lond). 1981;61(4):463&#x02013;9.<pub-id pub-id-type="pmid">7026128</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Passias</surname><given-names>TC</given-names></name><name><surname>Meneilly</surname><given-names>GS</given-names></name><name><surname>Mekjavi&#x00107;</surname><given-names>IB</given-names></name></person-group><article-title>Effect of hypoglycemia on thermoregulatory responses</article-title><source>J Appl Physiol</source><year>1996</year><volume>80</volume><issue>3</issue><fpage>1021</fpage><lpage>1032</lpage><pub-id pub-id-type="doi">10.1152/jappl.1996.80.3.1021</pub-id><pub-id pub-id-type="pmid">8964720</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Passias TC, Meneilly GS, Mekjavi&#x00107; IB. Effect of hypoglycemia on thermoregulatory responses. J Appl Physiol. 1996;80(3):1021&#x02013;32.<pub-id pub-id-type="pmid">8964720</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Bridwell</surname><given-names>RE</given-names></name><name><surname>Willis</surname><given-names>GC</given-names></name><name><surname>Gottlieb</surname><given-names>M</given-names></name><name><surname>Koyfman</surname><given-names>A</given-names></name><name><surname>Long</surname><given-names>B</given-names></name></person-group><article-title>Decompensated hypothyroidism: A review for the emergency clinician</article-title><source>Am J Emerg Med</source><year>2021</year><volume>39</volume><fpage>207</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.ajem.2020.09.062</pub-id><pub-id pub-id-type="pmid">33039222</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Bridwell RE, Willis GC, Gottlieb M, Koyfman A, Long B. Decompensated hypothyroidism: A review for the emergency clinician. Am J Emerg Med. 2021;39:207&#x02013;12.<pub-id pub-id-type="pmid">33039222</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>AJ</given-names></name><name><surname>Castellani</surname><given-names>JW</given-names></name></person-group><article-title>Exertional fatigue and cold exposure: mechanisms of hiker's hypothermia</article-title><source>Appl Physiol Nutr Metab</source><year>2007</year><volume>32</volume><issue>4</issue><fpage>793</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1139/H07-041</pub-id><pub-id pub-id-type="pmid">17622297</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Young AJ, Castellani JW. Exertional fatigue and cold exposure: mechanisms of hiker&#x02019;s hypothermia. Appl Physiol Nutr Metab. 2007;32(4):793&#x02013;8.<pub-id pub-id-type="pmid">17622297</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Blunk</surname><given-names>JA</given-names></name><name><surname>Schmelz</surname><given-names>M</given-names></name><name><surname>Zeck</surname><given-names>S</given-names></name><name><surname>Skov</surname><given-names>P</given-names></name><name><surname>Likar</surname><given-names>R</given-names></name><name><surname>Koppert</surname><given-names>W</given-names></name></person-group><article-title>Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin</article-title><source>Anesth Analg</source><year>2004</year><volume>98</volume><issue>2</issue><fpage>364</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1213/01.ANE.0000097168.32472.0D</pub-id><pub-id pub-id-type="pmid">14742371</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Blunk JA, Schmelz M, Zeck S, Skov P, Likar R, Koppert W. Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin. Anesth Analg. 2004;98(2):364&#x02013;70.<pub-id pub-id-type="pmid">14742371</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Flacke</surname><given-names>JW</given-names></name><name><surname>Flacke</surname><given-names>WE</given-names></name><name><surname>Bloor</surname><given-names>BC</given-names></name><name><surname>Van Etten</surname><given-names>AP</given-names></name><name><surname>Kripke</surname><given-names>BJ</given-names></name></person-group><article-title>Histamine release by four narcotics: a double-blind study in humans</article-title><source>Anesth Analg</source><year>1987</year><volume>66</volume><issue>8</issue><fpage>723</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1213/00000539-198708000-00005</pub-id><pub-id pub-id-type="pmid">2440351</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Flacke JW, Flacke WE, Bloor BC, Van Etten AP, Kripke BJ. Histamine release by four narcotics: a double-blind study in humans. Anesth Analg. 1987;66(8):723&#x02013;30.<pub-id pub-id-type="pmid">2440351</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>AH</given-names></name><name><surname>McShane</surname><given-names>R</given-names></name><name><surname>Park</surname><given-names>SB</given-names></name><name><surname>Cowen</surname><given-names>PJ</given-names></name></person-group><article-title>Buspirone-induced hypothermia in normal male volunteers</article-title><source>Biol Psychiatry</source><year>1993</year><volume>34</volume><issue>9</issue><fpage>665</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1016/0006-3223(93)90161-6</pub-id><pub-id pub-id-type="pmid">8292697</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Young AH, McShane R, Park SB, Cowen PJ. Buspirone-induced hypothermia in normal male volunteers. Biol Psychiatry. 1993;34(9):665&#x02013;6.<pub-id pub-id-type="pmid">8292697</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Voronova</surname><given-names>IP</given-names></name></person-group><article-title>5-HT Receptors and Temperature Homeostasis</article-title><source>Biomolecules</source><year>2021</year><volume>11</volume><issue>12</issue><fpage>1914</fpage><pub-id pub-id-type="doi">10.3390/biom11121914</pub-id><pub-id pub-id-type="pmid">34944557</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Voronova IP. 5-HT Receptors and Temperature Homeostasis. Biomolecules. 2021;11(12):1914.<pub-id pub-id-type="pmid">34944557</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Sessler</surname><given-names>DI</given-names></name></person-group><article-title>Opioids and postoperative shivering</article-title><source>J Clin Anesth</source><year>2016</year><volume>31</volume><fpage>42</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.jclinane.2015.11.006</pub-id><pub-id pub-id-type="pmid">27185675</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Sessler DI. Opioids and postoperative shivering. J Clin Anesth. 2016;31:42&#x02013;3.<pub-id pub-id-type="pmid">27185675</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>